| Q40491235 | 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms |
| Q54661269 | 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations. |
| Q28253911 | An automated procedure to identify biomedical articles that contain cancer-associated gene variants |
| Q35770066 | An update on molecular genetics of gastrointestinal stromal tumours. |
| Q37800285 | Clinical implications of KIT and PDGFRA genotyping in GIST |
| Q57325993 | Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation ofSPP1as an independent prognostic factor |
| Q53588946 | Correlation of enhanced cell turnover with prognosis of gastrointestinal stromal tumors of the stomach: relevance of cellularity and p27kip1. |
| Q83269325 | Deletions of chromosome 1p and 15q are associated with aggressiveness of gastrointestinal stromal tumors |
| Q26799387 | Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions |
| Q38123108 | Epigenetics in gastrointestinal stromal tumors: clinical implications and potential therapeutic perspectives. |
| Q54650490 | Epithelioid/mixed phenotype in gastrointestinal stromal tumors with KIT mutation from the stomach is associated with accelerated passage of late phases of the cell cycle and shorter disease-free survival |
| Q40454254 | Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier's disease. |
| Q41909099 | Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma |
| Q44522889 | Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach |
| Q35119141 | Expression of DOG1, PDGFRA, and p16 in Gastrointestinal Stromal Tumors |
| Q49924821 | Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment |
| Q34928165 | Gastrointestinal stromal tumor - an evolving concept |
| Q82948349 | Gastrointestinal stromal tumors |
| Q46960807 | Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy |
| Q37176371 | Gastrointestinal stromal tumors: key to diagnosis and choice of therapy |
| Q36826588 | Gastrointestinal stromal tumour. |
| Q51037108 | Gastrointestinal stromal tumour. |
| Q36344295 | Gastrointestinal stromal tumours: an update |
| Q34633714 | Gastrointestinal stromal tumours: origin and molecular oncology. |
| Q37313165 | Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization |
| Q41694334 | Genetic progression in gastrointestinal stromal tumors: mechanisms and molecular interventions. |
| Q80509487 | Gigantic gastrointestinal stromal tumor in the pelvis |
| Q54587404 | Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor. |
| Q30438403 | Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis |
| Q51232554 | Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors. |
| Q58371721 | Inactivation of p16 by CpG hypermethylation in renal cell carcinoma |
| Q43621410 | Long-term follow-up in 54 surgically treated patients with gastrointestinal stromal tumours |
| Q47385250 | Loss of heterozygosity of chromosome 9p and loss of p16INK4A expression are associated with malignant gastrointestinal stromal tumors |
| Q38667013 | MicroRNAs and Gastrointestinal Stromal Tumor |
| Q36561734 | Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) |
| Q36293536 | Molecular research directions in the management of gastrointestinal stromal tumors |
| Q39288497 | Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors |
| Q35716915 | P16 protein expression in primary cutaneous melanoma with positive and negative lymph node biopsies: Particular aspects of a study performed at the Hospital de Clinicas de Porto Alegre, Brazil |
| Q38823874 | Promising novel therapeutic approaches in the management of gastrointestinal stromal tumors. |
| Q35847885 | Review of the molecular profile and modern prognostic markers for gastric lymphoma: how do they affect clinical practice? |
| Q39455238 | Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome |
| Q37005042 | The epidemiologic, health-related quality of life, and economic burden of gastrointestinal stromal tumours |
| Q36019315 | Update on the biology and therapy of gastrointestinal stromal tumors |
| Q50575961 | What is New in Gastrointestinal Stromal Tumor? |
| Q80376979 | [DNA methylation on urinalysis and as a prognostic marker in urothelial cancer of the bladder] |
| Q84757222 | [Molecular biological evaluation of prognostic parameters in GIST. Development of an integrative model of tumor progression] |
| Q36897784 | p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome |
| Q47686988 | p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas |